InvestorsHub Logo
Followers 2
Posts 118
Boards Moderated 0
Alias Born 05/17/2013

Re: pharmeng post# 16805

Thursday, 07/27/2017 11:55:18 PM

Thursday, July 27, 2017 11:55:18 PM

Post# of 34626
Tapimmune corporate presentation notes FRa expressed in 80% NSCLC. I'm not a scientist but AZN ovarian combo trial results may beg the question of what does that combo look like in NSCLC. Also a more recent update on the IMGN FRa targeted ADC

http://investor.immunogen.com/releasedetail.cfm?ReleaseID=1026885

AIDS became a lifelong treatable disease through combo (cocktail) approaches. Cure could be around the corner.

So much research going on
hopefully most cancers are next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News